Sun Pharma announces approval to mkt Tessalon

Quotes with Resistance & Support

Market Information

Sun Pharma announces approval to mkt Tessalon

This article was posted on Mar 24, 2008 and is filed under Press Releases

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted approval for the Abbreviated New Drug Application (ANDA) to market a generic version of Forest Lab’s Tessalon®, benzonatate capsules.

Benzonatate USP capsules are therapeutically equivalent to Forest Lab’s Tessalon®, and are available in two strengths: capsules containing 100 mg and 200 mg benzonatate USP.

Benzonatate has annual sales of approximately USD 40 million in the US.

Benzonatate is an antitussive, used to relieve cough due to the common cold, bronchitis, pneumonia, or other lung infections.

This product will reach market shortly.

Sourced From: Sun Pharmaceutical Industries Ltd

Tags: calls, daytrading, free calls, intraday, tips

Note: The Credit of this post goes to the original witters of this post and not to NSEGUIDE

Breakouts

+ve » Positive / -ve » Negative

+ve 30 DMA 50 DMA 150 DMA 200 DMA

-ve 30 DMA 50 DMA 150 DMA 200 DMA

Latest Query

Post my query

Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam

Status: Awaiting reply

Market Stats

Search Our Archives

Research Desk

Stocks Trading above their 50 day moving average - DMA In Stock Research
Download free Ebooks based on Technical Analysis In Personal Training
TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
Charting Pathsala - Your guide to Techincals In Technical Analysis